Chairman of the Board, Chief Executive Officer and President at OncoMed Pharmaceuticals, Inc.
Mr. Hastings has served as a director since June 2011 and as our Lead Director since June 2013. Mr. Hastings has been the President and Chief Executive Officer and a member of the board of directors of OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED), a clinical development-stage biopharmaceutical company, since January 2006. In August 2013, he was elected chairman of the board. Prior to joining OncoMed, Mr. Hastings was President and Chief Executive Officer of QLT, Inc., a biotechnology company focused on the development and commercialization of ocular products. Before this role, Mr. Hastings served as President and Chief Executive Officer of Ax ...
Source: Pacira Pharmaceuticals, Inc. on 04/13/2017
By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Paul J. Hastings. More specifically, you'll be able to:
Search for over 360,000 executive profiles.
Example: Paul J. Hastings
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.